Video Experimental Relacionado
Updated: Sep 9, 2025

11:47
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
10.7K
La N-acetilcarnosina atenúa las disminuciones asociadas a la edad en los sistemas multiorgánicos para mejorar la
bioRxiv : the preprint server for biology
|September 5, 2025
Resumen
La N-acetilcarnosina, un compuesto natural, prolongó significativamente la vida útil y mejoró la salud en ratones envejecidos. Este tratamiento con dipeptídeo que contiene histidina (HCD) evitó múltiples enfermedades relacionadas con la edad, ofreciendo una vía prometedora para un envejecimiento saludable.
Área de la Ciencia:
- Gerontología y Salud Metabólica
- Biología molecular y celular
- Farmacología y Terapia
Sus antecedentes:
- Los dipeptidos que contienen histidina (HCD), incluida la N-acetilcarnosina, son metabolitos endógenos con beneficios ergonómicos y metabólicos conocidos.
- Investigaciones anteriores indicaron la eficacia de la N-acetilcarnosina en la prevención de la atrofia muscular por falta de uso durante períodos cortos.
Objetivo del estudio:
- Investigar los efectos a largo plazo de la N-acetilcarnosina sobre las enfermedades asociadas a la edad y la supervivencia en un modelo de mamíferos.
- Evaluar exhaustivamente el impacto de la N-acetilcarnosina en varios sistemas de órganos durante el envejecimiento.
Principales métodos:
- Se administró un régimen de tratamiento de 6 meses de N-acetilcarnosina a ratones hembras.
- Se realizó un amplio estudio de los sistemas de órganos para evaluar los cambios fisiológicos relacionados con la edad.
- Se midieron los principales indicadores de salud, incluida la adiposidad, la función cardíaca, la vasodilatación, la fuerza muscular y la densidad ósea.
Principales resultados:
- El tratamiento con N-acetilcarnosina atenuó significativamente una amplia gama de enfermedades asociadas a la edad en ratones hembras.
- Las tasas de supervivencia mejoraron en aproximadamente un 50% en el grupo tratado con N-acetilcarnosina.
- El tratamiento evitó la disminución de la adiposidad, la función diastólica, la vasodilatación, la fuerza muscular y la densidad ósea.
Conclusiones:
- La N-acetilcarnosina retrasa sustancialmente el inicio de la patología sistémica terminal, prolongando así la vida útil.
- Como metabolito endógeno, la N-acetilcarnosina representa una intervención potencialmente segura y efectiva para promover el envejecimiento saludable.
- Se requiere una mayor investigación sobre la N-acetilcarnosina como terapéutico antienvejecimiento humano.
Videos de Conceptos Relacionados
Aging
174
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
174
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
The Effect of Aging on Tissues
2.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.4K
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666

